EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

SARS‐CoV‐2 Infection Is Associated With an Increased Risk of Hospital‐Treated Infectious Mononucleosis due to EBV: National Register‐Based Cohort Study

Snieguole Vingeliene iD, Huiqi Li, Helena Backman, Ruzan Udumyan, Johan Jendeberg, Gunlög Rasmussen, Martin Sundqvist, Marleen A H Lentjes, Katja Fall, Ayako Hiyoshi, Fredrik Nyberg, Scott Montgomery

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70787 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Snieguole Vingeliene und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: Infectious Mononucleosis, COVID-19, Epstein-Barr Virus Infections. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nyckelfonden, Avtal om Läkarutbildning och Forskning/Medical Training and Research Agreement, Forskningsrådet för hälsa, arbetsliv och välfärd/Research Council for Health, Working Life, and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is evidence that persistent dysregulation of the immune system caused by SARS‐CoV‐2 infection may increase susceptibility to other infections. Here, we assessed whether it is associated with subsequent diagnoses of infectious mononucleosis due to Epstein‐Barr virus (EBV‐IM). Residents of Sweden aged 3–100 years without a prior diagnosis of EBV‐IM were followed between January 1, 2020, and November 30, 2022, comprising a total of 9 978 860 participants. Individuals were categorized into those without a COVID‐19 diagnosis, those with a positive SARS‐CoV‐2 polymerase chain reaction (PCR) test only – less severe exposure, and those admitted to hospital with COVID‐19 – more severe exposure. Cox regression was used to estimate hazard ratios (HR) with 95% confidence intervals (95% CI) for the association between the exposure, modeled as a time‐varying covariate, and EBV‐IM occurrence. EBV‐IM rates per 100 000 person‐years and 95% CIs were 4.6 (4.4–4.9) for individuals not diagnosed with COVID‐19, 7.8 (6.9–8.9) for those with a positive SARS‐CoV‐2 test only, and 10.5 (6.2–17.6) for patients admitted to hospital with COVID‐19. HR and 95% CI were 1.61 (1.39–1.88) for people with a positive PCR test only and 5.71 (3.33–9.79) for those admitted to hospital with COVID‐19 compared with people without a COVID‐19 diagnosis, after adjustment for birth year, sex, Swedish healthcare region, region of birth, and Charlson comorbidity index. SARS‐CoV‐2 infection was associated with a subsequent raised risk of EBV‐IM, including among those with less severe acute infection, signaling immune perturbation and the possibility of further delayed sequelae linked with EBV‐IM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infectious MononucleosisCOVID-19Epstein-Barr Virus InfectionsHumansMaleChildFemaleSwedenAdolescentMiddle AgedChild, PreschoolAdultAgedYoung AdultHospitalizationHerpesvirus 4, HumanAged, 80 and overCohort StudiesRegistriesSARS-CoV-2Risk Factors

Stichwörter der Autor:innen

Epstein‐Barr virusSARS‐CoV‐2infectious mononucleosisregister study

Autor:innen und Institutionen

  • Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

ORCID-Profile: Snieguole Vingeliene

Förderung

  • Nyckelfonden
  • Avtal om Läkarutbildning och Forskning/Medical Training and Research Agreement
  • Forskningsrådet för hälsa, arbetsliv och välfärd/Research Council for Health, Working Life, and Welfare
  • Forskningsrådet för miljö, areella näringar och samhällsbyggande/Research Council for Environment, Agricultural Sciences and Spatial Planning

Zitieren

APA

Vingeliene, S., Li, H., Backman, H., Udumyan, R., Jendeberg, J., Rasmussen, G., Sundqvist, M., Lentjes, M. A. H., Fall, K., Hiyoshi, A., Nyberg, F., & Montgomery, S. (2026). SARS‐CoV‐2 Infection Is Associated With an Increased Risk of Hospital‐Treated Infectious Mononucleosis due to EBV: National Register‐Based Cohort Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70787

Vancouver

Vingeliene S, Li H, Backman H, Udumyan R, Jendeberg J, Rasmussen G, et al. SARS‐CoV‐2 Infection Is Associated With an Increased Risk of Hospital‐Treated Infectious Mononucleosis due to EBV: National Register‐Based Cohort Study. Journal of Medical Virology. 2026. doi:10.1002/jmv.70787

BibTeX
@article{Vingeliene2026,
  author = {Vingeliene, Snieguole and Li, Huiqi and Backman, Helena and Udumyan, Ruzan and Jendeberg, Johan and Rasmussen, Gunlög and Sundqvist, Martin and Lentjes, Marleen A H and Fall, Katja and Hiyoshi, Ayako and Nyberg, Fredrik and Montgomery, Scott},
  title = {SARS‐CoV‐2 Infection Is Associated With an Increased Risk of Hospital‐Treated Infectious Mononucleosis due to EBV: National Register‐Based Cohort Study},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70787}
}
Kostenlos starten →